Our study expands the GLB1 gene mutation spectrum of GM1 gangliosidosis, emphasizes the importance of WES in evaluating patients with undiagnosed genetic diseases, and provides a new basis for genetic counseling. This evidence concerns the gene GLB1 and GM1 gangliosidosis.